Scrip’s Five Must-Know Things – 14 August 2023

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: Wegovy’s solid new trial results; Lilly’s sales swing back; nothing off the table for new Bayer boss; new compliance crackdown in China; and McKinsey on AI. https://scrip.pharmaintelligence.informa.com/SC148876/Quick-Listen-Scrips-Five-MustKnow-Things